Abstract
Twenty-eight episodes of Streptococcus pneumoniae bacteremia occurring in 27 cancer patients hospitalized in the Institut Jules Bordet between July 1979 and April 1985 were reviewed. Ten patients had hematological malignancies and 17 had solid tumors (in 7 cases, of the lung). Forty-four per cent of the patients were neutropenic (<1000/μl) and 36% of the patients were in septic shock. In 36% of the patients, no clinical source of S. pneumoniae bacteremia could be found. Seventy-nine (21% patients) received empirical antibiotic treatment containing a beta-lactam. Two patients who did not receive any empirical treatment died within 12 hours. Overall, 11/27 patients died within the first week, and 8/27 died within the first three days. Mortality in neutropenic patients was not different from that in non-neutropenic patients. In comparison with a similar study performed previously in our institution, there was no difference in incidence, type of patient, source of bacteremia, or mortality.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
AlvarezR., GuarderasJ., ShellC.G. et al. (1986): Nosocomial pneumococcal bacteremia. - Arch. Intern. Med., 146: 1509–1512
AustrianR., GoldJ. (1964): Pneumococcal bacteremia with especial reference to bacteremic pneumococcal pneumonia. - Ann. Intern. Med., 60: 759–776.
AustrianR. (1981): Some observations on the pneumococcas and on the current status of pneumococcal disease and its prevention. - Rev. Inf. Dis., 3: (suppl): 1–17.
BartlettJ.G., O'KeefeP., TallyF.P. et al. (1986): Bacteriology of hospital-acquired pneumonia. -Arch. Intern. Med., 146: 686–871.
BernardC., MonbelliG., KlasterskyJ. (1981) Pneumococcal bacteremia in patients with neoplastic diseases. - Eur. J. Cancer Clin. Oncol., 17: 1041–1046.
BolanG., BroomeC.V., FacklamR.R. et al. (1986): Pneumococcal vaccine efficacy in selected populations in the United States. - Ann. Intern. Med., 104: 1–6.
Centers for disease control, Department of Health and Human Services. 1984. Update: pneumococcal polysaccharide vaccine usage. United States. Recommendations of the Immunization Practice advisory Committee. - Ann. Intern. Med., 101: 348–350.
ChouM.Y., BrownA.E., BlevinsA. et al. (1983): Severe pneumococcal infection in patients with neoplastic disease. - Cancer., 51: 1546–1550.
EORTC International Antimicrobial Therapy project group (1986): Prospective randomized comparison of three antibiotic regimens for empirical therapy of suspected bacteremic infection in febrile granulocytopenic. - Antimicrob. Ag. and Chemother., 29: 263–270.
EORTC International Antimicrobial Therapy project group (1986): Gram-positive septicemia in cancer patients. Program and abstracts of the 26th Interscience conference on Antimicrobial Agents and Chemotherapy, New Orleans, American Society for Clinical Microbiology (ed), Washington. DC. Abstract 679, p. 222.
FollandD., ArmstrongD., SeidesS. et al. (1974): Pneumococcal bacteremia in patients with neoplastic disease. - Cancer., 33: 845–849.
Health and Public Policy Committee, American College of Physicians (1986): Pneumococcal vaccine. -Ann. Intern. Med., 104: 79–86.
KlasterskyJ., MommenP., CantraineF. et al. (1986): Placebo controlled pneumococcal immunization in patients with bronchogenic carcinoma. -Eur. J. Cancer Clin. Oncol., 22: 807–813.
LandermanS.H., SchiffmanG. (1981): Assessment of the antibody response to pneumococcal vaccine in high-risk populations. - Rev. Infect. Dis., 3 (suppl.): 184–196.
LennetteE.H., BalowsA., HauslerW.J.Jr., TruantJ.P. (1980): Manual of Clinical Microbiology, 3rd edition. American Society for Microbiology. Washington D.C.
PizzoP.A., LadischS., SimonR.M., GillF., LevineA.S. (1978): Increasing incidence of Gram-positive sepsis in cancer patients. - Med. Pediat. Oncol., 5: 241–244.
RytelM.W. (1979): Pneumococcal pneumoniae. In: Rytel M.W. (ed.). Rapid diagnosis in infectious disease. CRC Press, Inc. Boca Raton, Florida; p. 91–103.
ShapiroE.D., ClemensJ.D. (1984): A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections. - Ann. Intern. Med., 101: 325–330.
WadeJ.C., SchimpffS.C., NewmanK.A., WiernikP.H. (1982): Staphylococcus epidermidis: an increasing cause of infection in patients with granulocytopenia. -Ann. Intern. Med., 96: 1–10.
WaraD.W. (1981): Host defense against Streptococcus pneumoniae: the role of the spleen. - Rev. Infect. Dis., 3: 299–309.
WinstonD.J., SchiffmanG., WangD.C. et al. (1979): Pneumococcal infections after human bone-marrow transplantation. - Ann. Intern. Med., 91: 835–841.
WinstonD.J., DudnickD.V., ChampinM., HoW.G., SaleR.P., MartinM.J. (1983): Coagulase negative staphylococcal bacteremia in patients receiving immunosuppressive therapy. - Arch. Intern. Med., 143: 32–36.
WoodhaedM.A., MacfarlaneJ.T., RodgersR.G. et al., PilkingtonR. (1985): Aetiology and outcome of severe community-acquired pneumonia. - J. Infect., 10: 204–210.
ZarrabiM.H., RosnerF. (1986): Rarity of failure of penicillin prophylaxis to prevent postsplenoctomy sepsis. - Arch. Intern. Med., 146: 1207–1208.
Author information
Authors and Affiliations
Additional information
Corresponding author.
Rights and permissions
About this article
Cite this article
Richard, V., Meunier, F., Van Der Auwera, P. et al. Pneumococcal bacteremia in cancer patients. Eur J Epidemiol 4, 242–245 (1988). https://doi.org/10.1007/BF00144760
Issue Date:
DOI: https://doi.org/10.1007/BF00144760